Brigatinib

INN name:	Brigatinib
Lab codes:	AP-26113
Chemical name:	2-[(5-chloro-2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}pyrimidin-4-yl)amino]phenyl}dimethyl-λ5-phosphanone
Molecular formula:	C29H39ClN7O2P
Chemical Structure:
CAS Registry Number:	1197953-54-0
Originator:	ARIAD Pharmaceuticals
Class:	Antineoplastics
Mechanism of Action:	Tyrosine kinase inhibitor
WHO ATC code:	L01X-E (Protein kinase inhibitors)
EPhMRA code:	L1H (Protein Kinase Inhibitor Antineoplastics)
Clinical Trials: Indication Phase Status Non-small Cell Lung Cancer Phase 2 Recruiting Advanced Malignancies;   Carcinoma, Non-Small-Cell Lung;   Anaplastic Large Cell Lymphoma;   Diffuse Large Cell Lymphoma;   Inflammatory Myofibroblastic Tumors Phase 1 / Phase 2 Active, not recruiting
Product Patent Expiry: For patent data contact us at drugpatentexpiry@gmail.com